Αρχειοθήκη ιστολογίου

Τετάρτη 10 Οκτωβρίου 2018

Evaluation of CA 19-9, a predictive biomarker of response and survival in patients undergoing chemotherapy for metastatic pancreatic ductal adenocarcinoma

Alrifai, D; (2017) Evaluation of CA 19-9, a predictive biomarker of response and survival in patients undergoing chemotherapy for metastatic pancreatic ductal adenocarcinoma. Presented at: ESMO World Congress on Gastrointestinal Cancer 2018, Barcelona, Spain.

https://ift.tt/2QEWzO8

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου